$MNTS
Momentus Inc. Stock $mnts

$mnts Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000178116223000015 Filed on March 08, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$22.00K	$120.0K	$299.0K
YoY Change			-9.39%
Cost Of Revenue		$0.00	$26.00K
YoY Change			-126.0%
Gross Profit	$22.00K	$120.0K	$273.0K
YoY Change			-41.29%
Gross Profit Margin	100.0%	100.0%	91.3%
Selling, General & Admin	$10.27M	$10.93M	$49.83M
YoY Change	-30.86%	-16.59%	1.89%
% of Gross Profit	46681.82%	9107.5%	18251.65%
Research & Development	$10.12M	$10.28M	$41.72M
YoY Change	1.48%	-11.15%	-18.71%
% of Gross Profit	45995.45%	8569.17%	15282.42%
Depreciation & Amortization	$200.0K	$259.0K	$1.000M
YoY Change	-33.33%	-20.06%	0.0%
% of Gross Profit	909.09%	215.83%	366.3%
Operating Expenses	$20.39M	$21.21M	$91.55M
YoY Change	-17.87%	-14.04%	-8.66%
Operating Profit	-$20.37M	-$21.09M	-$91.28M
YoY Change	-17.95%		-8.51%
Interest Expense	$920.0K	-$607.0K	$5.262M
YoY Change	-38.34%		-63.02%
% of Operating Profit
Other Income/Expense, Net	-$458.0K	$1.813M	-$4.169M
YoY Change	-77.21%	-93.41%	-101.89%
Pretax Income	-$20.83M	-$24.44M	-$95.44M
YoY Change	-22.39%	795.57%	-179.1%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$20.80M	-$24.44M	-$95.44M
YoY Change	-22.49%	795.24%	-179.11%
Net Earnings / Revenue	-94545.45%	-20366.67%	-31921.07%
Basic Earnings Per Share	-$0.24		-$1.17
Diluted Earnings Per Share	-$0.24	-$0.30	-$1.17
COMMON SHARES
Basic Shares Outstanding	94.06M shares	84.15M shares	81.55M shares
Diluted Shares Outstanding	87.56M shares		81.55M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$38.63M	$61.09M	$61.09M
YoY Change	-71.51%	-61.82%	-61.82%
Cash & Equivalents	$38.60M	$61.09M	$61.09M
Short-Term Investments
Other Short-Term Assets	$10.40M	$11.18M	$11.18M
YoY Change	28.69%	16.12%	16.46%
Inventory
Prepaid Expenses
Receivables		$0.00
Other Receivables
Total Short-Term Assets	$53.03M	$76.27M	$76.27M
YoY Change	-63.09%	-55.04%	-55.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.844M	$4.016M	$10.46M
YoY Change	-18.66%	-16.84%	-15.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.670M	$4.712M	$5.355M
YoY Change	-18.78%	53.74%	57.5%
Total Long-Term Assets	$15.81M	$16.15M	$16.15M
YoY Change	-15.63%	-0.07%	0.3%
TOTAL ASSETS
Total Short-Term Assets	$53.03M	$76.27M	$76.27M
Total Long-Term Assets	$15.81M	$16.15M	$16.15M
Total Assets	$68.84M	$92.42M	$92.42M
YoY Change	-57.62%	-50.26%	-50.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.092M	$2.239M	$2.239M
YoY Change	-36.39%	17.16%	17.84%
Accrued Expenses	$6.496M	$8.026M	$9.179M
YoY Change	-32.11%	-17.98%	-16.55%
Deferred Revenue	$2.136M	$1.654M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$11.29M	$11.63M	$11.63M
YoY Change	19.7%	-44.39%	-44.37%
Total Short-Term Liabilities	$31.73M	$43.23M	$43.23M
YoY Change	-8.08%	11.22%	11.12%
LONG-TERM LIABILITIES
Long-Term Debt	$171.0K	$2.404M	$2.404M
YoY Change	-98.49%
Other Long-Term Liabilities	$471.0K	$465.0K	$8.186M
YoY Change	-3.48%	-3.73%	-45.79%
Total Long-Term Liabilities	$8.165M	$10.59M	$10.59M
YoY Change	-69.36%	-29.73%	-29.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.73M	$43.23M	$43.23M
Total Long-Term Liabilities	$8.165M	$10.59M	$10.59M
Total Liabilities	$39.90M	$53.82M	$53.82M
YoY Change	-34.78%	-0.22%	-0.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$325.0M	-$304.1M
YoY Change	37.99%	45.74%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.95M	$38.61M	$38.61M
YoY Change
Total Liabilities & Shareholders Equity	$68.84M	$92.42M	$92.42M
YoY Change	-57.62%	-50.26%	-50.26%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$20.80M	-$24.44M	-$95.44M
YoY Change	-22.49%	795.24%	-179.11%
Depreciation, Depletion And Amortization	$200.0K	$259.0K	$1.000M
YoY Change	-33.33%	-20.06%	0.0%
Cash From Operating Activities	-$18.70M	-$16.39M	-$87.89M
YoY Change	-18.91%	12.4%	1.36%
INVESTING ACTIVITIES
Capital Expenditures	$43.00K	$119.0K	$583.0K
YoY Change	-85.17%	-149.79%	-80.38%
Acquisitions
YoY Change
Other Investing Activities		$27.00K	$34.00K
YoY Change
Cash From Investing Activities	-$52.00K	-$92.00K	-$733.0K
YoY Change	-90.02%	-61.34%	-76.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$3.793M	-3.270M	-$9.514M
YoY Change	304.37%	-14.49%	-104.19%
NET CHANGE
Cash From Operating Activities	-$18.70M	-16.39M	-$87.89M
Cash From Investing Activities	-$52.00K	-92.00K	-$733.0K
Cash From Financing Activities	-$3.793M	-3.270M	-$9.514M
Net Change In Cash	-$22.54M	-19.75M	-$98.13M
YoY Change	-8.07%	5.95%	-171.62%
FREE CASH FLOW
Cash From Operating Activities	-$18.70M	-$16.39M	-$87.89M
Capital Expenditures	$43.00K	$119.0K	$583.0K
Free Cash Flow	-$18.74M	-$16.51M	-$88.47M
YoY Change	-19.74%	15.11%	-1.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001781162
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ServiceMember
CY2021	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ServiceMember
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39128
CY2022	dei	Entity Registrant Name EntityRegistrantName	Momentus Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1905538
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	3901 N. First Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95134
CY2022	dei	City Area Code CityAreaCode	650
CY2022	dei	Local Phone Number LocalPhoneNumber	564-7820
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q4	us-gaap	Assets Current AssetsCurrent	76274000	usd
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	137100000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	94056124	shares
CY2022	dei	Auditor Firm AuditorFirmId	32
CY2022	dei	Auditor Name AuditorName	Armanino LLP
CY2022	dei	Auditor Location AuditorLocation	San Ramon, CA
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61094000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160036000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1007000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	197000	usd
CY2022Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	4000000	usd
CY2021Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10173000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9431000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	169664000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4016000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9785000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4829000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	337000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6441000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7604000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	331000	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	0	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	312000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	314000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4712000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3065000	usd
CY2022Q4	us-gaap	Assets Assets	92423000	usd
CY2021Q4	us-gaap	Assets Assets	185825000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2239000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1911000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8026000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	11627000	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	20907000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1654000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1153000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1189000	usd
CY2022Q4	mnts	Share Repurchase Liability Current ShareRepurchaseLiabilityCurrent	10000000	usd
CY2021Q4	mnts	Share Repurchase Liability Current ShareRepurchaseLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	8500000	usd
CY2021Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	27000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5075000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	43226000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38867000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1026000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1554000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	2404000	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	usd
CY2022Q4	mnts	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	564000	usd
CY2021Q4	mnts	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	5749000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6131000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7284000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	465000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	483000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10590000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15070000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	53816000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	53937000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84441153	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84441153	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81211781	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81211781	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	342733000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	340570000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-304127000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-208683000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	38607000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	131888000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	92423000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	185825000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	299000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	330000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	-135000	usd
CY2022	us-gaap	Gross Profit GrossProfit	273000	usd
CY2021	us-gaap	Gross Profit GrossProfit	465000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41721000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51321000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49827000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48905000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	91548000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	100226000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-91275000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-99761000	usd
CY2022	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	0	usd
CY2021	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	209291000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5185000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-37330000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-168000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-17000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	522000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000	usd
CY2022	us-gaap	Interest Expense InterestExpense	5262000	usd
CY2021	us-gaap	Interest Expense InterestExpense	14229000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	54000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4960000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4169000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	220417000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-95444000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	120656000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-95444000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	120654000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.17
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.85
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.17
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81546648	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65177873	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81546648	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70918777	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-289472000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	336000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18382000	usd
CY2021	mnts	Stock Issued During Period Value Section16 Officer Tax Coverage Exchange StockIssuedDuringPeriodValueSection16OfficerTaxCoverageExchange	151000	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	40000000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6999000	usd
CY2021	mnts	Stock Issued During Period Value Conversion Of Safe Notes StockIssuedDuringPeriodValueConversionOfSAFENotes	136001000	usd
CY2021	mnts	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	75114000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	104022000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	120654000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	131888000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	574000	usd
CY2022	mnts	Stock Issued During Period Purchase Of Employee Share Purchase Plan StockIssuedDuringPeriodPurchaseOfEmployeeSharePurchasePlan	271000	usd
CY2022	mnts	Stock Issued During Period Value Section16 Officer Tax Coverage Exchange StockIssuedDuringPeriodValueSection16OfficerTaxCoverageExchange	331000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11649000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-10000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-95444000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	38607000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-95444000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	120654000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1090000	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1092000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2690000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11729000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1163000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1285000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5185000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-37330000	usd
CY2022	mnts	Fair Value Adjustment Of Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentOfFinancialInstrumentsSubjectToMandatoryRedemption	0	usd
CY2021	mnts	Fair Value Adjustment Of Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentOfFinancialInstrumentsSubjectToMandatoryRedemption	-209291000	usd
CY2022	mnts	Prepaid Launch Costs Impairment Charges PrepaidLaunchCostsImpairmentCharges	0	usd
CY2021	mnts	Prepaid Launch Costs Impairment Charges PrepaidLaunchCostsImpairmentCharges	9450000	usd
CY2022	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-168000	usd
CY2021	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-17000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	11580000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	18452000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2206000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	14373000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	147000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	325000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	373000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1562000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1540000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7042000	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	131000	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-5020000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	4810000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1126000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1071000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1189000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-426000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	23000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	11000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-87887000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-86712000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	583000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2972000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	34000	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	184000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	118000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-733000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3090000	usd
CY2022	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	0	usd
CY2021	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	30853000	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	25000000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	574000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	336000	usd
CY2022	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	271000	usd
CY2021	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	0	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	331000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	151000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	9697000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1500000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	144000	usd
CY2022	mnts	Payment Of Warrant Issuance Costs PaymentOfWarrantIssuanceCosts	0	usd
CY2021	mnts	Payment Of Warrant Issuance Costs PaymentOfWarrantIssuanceCosts	31000	usd
CY2022	mnts	Payment Of Deferred Offering Costs PaymentOfDeferredOfferingCosts	331000	usd
CY2021	mnts	Payment Of Deferred Offering Costs PaymentOfDeferredOfferingCosts	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	40000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	usd
CY2022	mnts	Payments Of Stock Issuance Costs Related To Private Placement PaymentsOfStockIssuanceCostsRelatedToPrivatePlacement	0	usd
CY2021	mnts	Payments Of Stock Issuance Costs Related To Private Placement PaymentsOfStockIssuanceCostsRelatedToPrivatePlacement	4416000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	128167000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	21285000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9514000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	226829000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-98134000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	137027000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160547000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23520000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62413000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160547000	usd
CY2022	mnts	Conversion Of Simple Agreement For Future Equity Issuance To Common Stock ConversionOfSimpleAgreementForFutureEquityIssuanceToCommonStock	0	usd
CY2021	mnts	Conversion Of Simple Agreement For Future Equity Issuance To Common Stock ConversionOfSimpleAgreementForFutureEquityIssuanceToCommonStock	136001000	usd
CY2022	mnts	Issuance Of Common Stock Warrant Liabilities Exercised IssuanceOfCommonStockWarrantLiabilitiesExercised	0	usd
CY2021	mnts	Issuance Of Common Stock Warrant Liabilities Exercised IssuanceOfCommonStockWarrantLiabilitiesExercised	6999000	usd
CY2022	mnts	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	0	usd
CY2021	mnts	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	2610000	usd
CY2022	mnts	Warrant Liabilities Recognized Upon The Closing Of The Reverse Recapitalization WarrantLiabilitiesRecognizedUponTheClosingOfTheReverseRecapitalization	0	usd
CY2021	mnts	Warrant Liabilities Recognized Upon The Closing Of The Reverse Recapitalization WarrantLiabilitiesRecognizedUponTheClosingOfTheReverseRecapitalization	31225000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8501000	usd
CY2022	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	10000000	usd
CY2021	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2440000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2500000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	Nature of Operations<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Momentus Inc. (together with its consolidated subsidiaries “Momentus” or the “Company”) is a U.S. commercial space company that offers in-space infrastructure services, including in-space transportation, hosted payloads and in-orbit services. Momentus believes it can make new ways of operating in space possible with its planned in-space transfer and service vehicles that will be powered by an innovative water plasma-based propulsion system that is under development. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 4, 2022, the Company received a favorable determination from the Federal Aviation Administration (the “FAA”) of its application for payload review, which was the final regulatory milestone needed to support the Company’s inaugural flight of the Vigoride orbital service vehicle (Vigoride 3) in May 2022. The FAA favorable determination followed a license from the Federal Communications Commission (the “FCC”) received on April 28, 2022, and updates to existing licenses from the National Oceanic and Atmospheric Administration (the “NOAA”).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 25, 2022, the Company launched Vigoride 3 to low-earth orbit aboard the SpaceX Transporter-5 mission. In addition to Vigoride 3, Momentus used a second port on the same SpaceX mission to fly a third-party deployer from a partner company. On May 25, 2022, Momentus used the third-party deployer to place its first customer satellite in orbit. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2022, upon establishing two-way contact between Vigoride 3 in low-earth orbit and a ground station on Earth, Momentus discovered that Vigoride 3 had experienced certain anomalies after its launch, primarily relating to its deployable solar arrays, which provide power to the spacecraft and its subsystems. The Company quickly worked to address the anomalies, identify root causes and pursue solutions to be implemented in advance of future missions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that Vigoride 3’s deployable solar arrays, which are produced by a third party, and are folded and stowed during launch, did not operate as intended once in orbit. This resulted in low power and communications issues with the spacecraft. Meanwhile, the spacecraft's fixed, body-mounted solar panels appeared to have worked as intended and were able to provide some power to the spacecraft. The Company and the producer of the solar arrays identified a mechanical issue as the root cause of the deployable arrays not operating as intended. The Company also identified the root cause of the anomalies that it experienced with other spacecraft systems during the low-power state.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2022, Momentus was able to deploy two customer satellites from Vigoride 3 (of nine total customer satellites onboard Vigoride 3). The Company then continued efforts to deploy other customer satellites. While Momentus initially established two-way communications with Vigoride 3, it was unable to continue such two-way communication given the spacecraft's low-power state. Momentus has been using an unplanned frequency to work through the anomalies and applied for a 30-day Special Temporary Authority (“STA”) from the FCC to properly comply with the FCC’s radio frequency transmission requirements. On June 9, 2022, the Company received approval of a 30-day STA from the FCC as requested, which the FCC extended for an additional 30 days on July 13, 2022. Momentus continued to apply for 30-day extensions for its STA prior to expiration, which the FCC has granted in each case, through October 20, 2022.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Momentus was unable to re-establish two-way communication with Vigoride 3, it continued to broadcast commands to the spacecraft from ground stations on Earth, including commands to deploy customer satellites. Additionally, Vigoride 3 was equipped with a mechanism designed to autonomously deploy customer satellites in the event of a sustained loss of communications with ground stations. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Vigoride spacecraft deployed five additional customer satellites including two on July 17, 2022, two on July 29, 2022, and one at the end of August 2022. In total, Momentus deployed a total of eight customer satellites in low-earth orbit during its inaugural mission, comprising seven satellites from Vigoride 3 and one satellite from the third-party deployer system. The Company was unable and remains unable to confirm the deployment of the last two customer satellites that Vigoride 3 was carrying. The Company incorporated improvements identified during its inaugural mission in advance of its first follow-on mission and other planned follow-on missions.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 3, 2023, the Company launched Vigoride 5 to low-earth orbit aboard the SpaceX Transporter-6 mission. The mission is ongoing and Vigoride 5 is in good health as it undergoes a deliberate commissioning process in preparation for on-orbit operations. On Vigoride’s first orbital pass, Momentus confirmed that both solar arrays were deployed, and the vehicle was generating power and charging its batteries. As of the date of this Annual Report on Form 10-K, the vehicle’s power and temperatures continue to be within the nominal expected ranges. While Vigoride 5 is carrying two customer payloads, the primary mission objective is to test the spacecraft on orbit, learn from any issues that are encountered and implement lessons learned on future Vigoride vehicles and missions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates flying two additional missions with Vigoride during 2023. All future missions remain subject to the receipt of licenses and government approvals, and successful completion of our efforts to prepare our spacecraft for flight. The Company can offer no assurances that the vehicles that it plans to operate in future missions will be ready on time, or that they will operate as intended. Refer to “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors — We may not receive all required governmental licenses and approvals,” and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors — We are dependent on the successful development of our satellite vehicles and related technology,” </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under Part I, Item 1A: "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," in this Annual Report on Form 10-K.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background and Business Combination</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company consummated a merger pursuant to certain Agreement and Plan of Merger, dated October 7, 2020, and as amended on March 5, 2021, April 6, 2021, and June 29, 2021 (the “Merger Agreement”), by and among Stable Road Acquisition Corp (“SRAC”), Project Marvel First Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of SRAC (the “First Merger Sub”), and Project Marvel Second Merger Sub, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of SRAC (the “Second Merger Sub”), pursuant to which the First Merger Sub merged with and into Momentus Inc., a Delaware corporation (“Legacy Momentus”), with Legacy Momentus as the surviving corporation of the First Merger Sub, and immediately following which Legacy Momentus merged with and into the Second Merger Sub, with the Second Merger Sub as the surviving entity (the “Business Combination”). In connection with the closing of the Business Combination (the “Closing”), the Company changed its name from Stable Road Acquisition Corp. to Momentus Inc., and Legacy Momentus changed its name to Momentus Space, LLC.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination was accounted for as a reverse recapitalization under ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ("ASC 805") in accordance with accounting principles generally accepted in the United States (“GAAP”). Under this method of accounting, SRAC, who was the legal acquirer, is treated as the “acquired” company for financial reporting purposes and Legacy Momentus is treated as the accounting acquirer. Accordingly, for accounting purposes, the Business Combination is treated as the equivalent of a capital transaction in which Legacy Momentus issued stock for the net assets of SRAC, with no goodwill or other intangible assets recorded, and Legacy Momentus’ financial statements became those of the Company. Reported shares and earnings per share available to holders of the Company’s Common Stock, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination. See Note 3 for more information.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended and Restated Certificate of Incorporation of the Company, at the Closing, each share of SRAC’s Class B Common Stock, par value $0.0001 per share (the “Class B Common Stock”), converted into one share of SRAC’s Class A Common Stock. After the Closing and following the effectiveness of the Second Amended and Restated Certificate of Incorporation of the Company, each share of Class A Common Stock was automatically reclassified, redesignated and changed into one validly issued, fully paid and non-assessable share of the Company’s Common Stock, par value $0.00001 per share (“Common Stock”), without any further action by the Company or any stockholder thereof.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, SRAC’s units, public shares, and public warrants were listed on the Nasdaq under the symbols “SRACU,” “SRAC,” and “SRACW,” respectively. On August 13, 2021, the Company's Common Stock and public warrants began trading on the Nasdaq, under the symbols “MNTS” and “MNTSW,” respectively.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2020 and July 15, 2021, SRAC entered into subscription agreements with certain investors (the “PIPE Investors”) to which such investors collectively subscribed for an aggregate of 11,000,000 shares of the Company’s Common Stock at $10.00 per share for aggregate gross proceeds of $110.0 million (the “PIPE Investment”). The PIPE Investors were also granted an equal number of private warrants to purchase the Company’s Common Stock at $11.50 per share. The warrants were recorded as a derivative liability under ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span></div>(“ASC 815”) and the warrant liability was initially valued at $30.5 million. See Note 11 for more information. The PIPE Investment was consummated concurrently with the closing of the Business Combination.
CY2022Q2	mnts	Number Of Customer Satellites Deployed NumberOfCustomerSatellitesDeployed	2	satellite
CY2022Q2	mnts	Number Of Customer Satellites NumberOfCustomerSatellites	9	satellite
CY2022Q2	mnts	Special Temporary Authority Period SpecialTemporaryAuthorityPeriod	P30D
CY2022Q2	mnts	Special Temporary Authority Period SpecialTemporaryAuthorityPeriod	P30D
CY2022Q2	mnts	Special Temporary Authority Period SpecialTemporaryAuthorityPeriod	P30D
CY2022Q2	mnts	Special Temporary Authority Extension Period SpecialTemporaryAuthorityExtensionPeriod	P30D
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	5	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	2	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	2	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	1	satellite
CY2022Q3	mnts	Number Of Customer Satellites Deployed In Low Earth Orbit NumberOfCustomerSatellitesDeployedInLowEarthOrbit	8	satellite
CY2022Q3	mnts	Number Of Internal Customer Satellites Deployed In Low Earth Orbit NumberOfInternalCustomerSatellitesDeployedInLowEarthOrbit	7	satellite
CY2022Q3	mnts	Number Of Third Party Customer Satellites Deployed In Low Earth Orbit NumberOfThirdPartyCustomerSatellitesDeployedInLowEarthOrbit	1	satellite
CY2022Q4	mnts	Number Of Customer Satellites Not Deployed NumberOfCustomerSatellitesNotDeployed	2	satellite
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	usd
CY2021Q3	mnts	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	30500000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company reclassified certain cloud computing implementation costs from intangible assets to prepaid and other current assets, and other non-current assets to properly present the capitalized costs with their related subscription fees. In accordance with ASC 350,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company presents capitalized implementation costs for cloud computing arrangements within the same line item that the prepayment of these fees would be presented. The reclassification was determined to be immaterial and will be accounted for prospectively.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, we modified the presentation of cash flows related to the Business Combination. The presented impact of the issuance costs allocated to expense (described in Note 3), was moved into the issuance costs line. Additionally the presentation of capitalized issuance costs which were paid during the two quarters prior to the Business Combination was updated to present those expenditures within cash flows from financing activities, rather than cash flows from operations.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other reclassifications have been made to the prior year’s consolidated financial statements to conform to the current year’s presentation. None of the reclassifications have changed the total assets, liabilities, stockholders’ equity (deficit), income, expenses or net losses previously reported.</span></div>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other factors it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Accordingly, actual results could differ from those estimates. Significant estimates inherent in the preparation of the consolidated financial statements include, but are not limited to, accounting for useful lives of property, machinery and equipment, net, intangible assets, net, accrued liabilities, income taxes including deferred tax assets and liabilities, impairment valuation, stock-based compensation, Simple Agreement for Future Equity (“SAFE”) notes, warrant liabilities and repurchase liabilities.
CY2022Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs DeferredFulfillmentAndPrepaidLaunchCosts	7400000	usd
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs DeferredFulfillmentAndPrepaidLaunchCosts	3000000	usd
CY2021	mnts	Number Of Launch Agreements Terminated NumberOfLaunchAgreementsTerminated	2	agreement
CY2022	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	usd
CY2022	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	usd
CY2021	mnts	Other Impairment Of Ongoing Project OtherImpairmentOfOngoingProject	800000	usd
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs Recoveries DeferredFulfillmentAndPrepaidLaunchCostsRecoveries	2700000	usd
CY2022Q2	mnts	Number Of Customer Satellites Deployed NumberOfCustomerSatellitesDeployed	2	satellite
CY2022Q2	mnts	Number Of Customer Satellites NumberOfCustomerSatellites	9	satellite
CY2022Q2	mnts	Special Temporary Authority Period SpecialTemporaryAuthorityPeriod	P30D
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	5	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	2	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	2	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	1	satellite
CY2022Q3	mnts	Number Of Customer Satellites Deployed In Low Earth Orbit NumberOfCustomerSatellitesDeployedInLowEarthOrbit	8	satellite
CY2022Q3	mnts	Number Of Internal Customer Satellites Deployed In Low Earth Orbit NumberOfInternalCustomerSatellitesDeployedInLowEarthOrbit	7	satellite
CY2022Q3	mnts	Number Of Third Party Customer Satellites Deployed In Low Earth Orbit NumberOfThirdPartyCustomerSatellitesDeployedInLowEarthOrbit	1	satellite
CY2022Q4	mnts	Number Of Customer Satellites Not Deployed NumberOfCustomerSatellitesNotDeployed	2	satellite
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1200000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12000	usd
CY2022Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	600000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	600000	usd
CY2022	mnts	Prepaid Launch Costs Impairment PrepaidLaunchCostsImpairment	1800000	usd
CY2022Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	14000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1000000	usd
CY2021Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	1400000	usd
CY2022	mnts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	2700000	usd
CY2021	mnts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	1600000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1600000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	50000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	133000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	129000	usd
CY2022Q3	mnts	Contract With Customer Liability Revenue Recognized For Cancelled Contracts ContractWithCustomerLiabilityRevenueRecognizedForCancelledContracts	28000	usd
CY2022Q3	mnts	Contract With Customer Liability Revenue Recognized Due To Uncertainties ContractWithCustomerLiabilityRevenueRecognizedDueToUncertainties	101000	usd
CY2022Q3	mnts	Contract With Customer Liability Variable Consideration ContractWithCustomerLiabilityVariableConsideration	33000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	120000	usd
CY2021	mnts	Contract With Customer Liability Revenue Recognized For Cancelled Contracts ContractWithCustomerLiabilityRevenueRecognizedForCancelledContracts	330000	usd
CY2021	mnts	Reduction In Cost Of Goods And Services Sold ReductionInCostOfGoodsAndServicesSold	135000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q4	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and cash equivalents in banks that management believes are creditworthy, however deposits may exceed federally insured limits.
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q3	mnts	Reverse Recapitalization Percentage Of Voting Interests Sold ReverseRecapitalizationPercentageOfVotingInterestsSold	1
CY2021Q3	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	247300000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	137300000	usd
CY2021Q3	mnts	Reverse Recapitalization Public Investment ReverseRecapitalizationPublicInvestment	172500000	usd
CY2021Q3	mnts	Reverse Recapitalization Redemptions ReverseRecapitalizationRedemptions	35600000	usd
CY2021Q3	mnts	Reverse Recapitalization Impact On Shareholders Equity ReverseRecapitalizationImpactOnShareholdersEquity	8500000	usd
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs Recoveries DeferredFulfillmentAndPrepaidLaunchCostsRecoveries	2700000	usd
CY2021Q3	mnts	Reverse Recapitalization Proceeds Received In Cash From Operations ReverseRecapitalizationProceedsReceivedInCashFromOperations	400000	usd
CY2021Q3	mnts	Reverse Recapitalization Net Proceeds Received From Shareholders ReverseRecapitalizationNetProceedsReceivedFromShareholders	238800000	usd
CY2021Q3	mnts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	27800000	usd
CY2021Q3	mnts	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	4800000	usd
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriod	P6M
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Stock Price Trigger ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodStockPriceTrigger	12.00
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodThresholdTradingDays	20	tradingday
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodThresholdConsecutiveTradingDays	30	tradingday
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	usd
CY2021Q3	mnts	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	30500000	usd
CY2021	us-gaap	Depreciation Depreciation	1000000	usd
CY2022Q4	mnts	Prepaid Launch Costs Current PrepaidLaunchCostsCurrent	3000000	usd
CY2021Q4	mnts	Prepaid Launch Costs Current PrepaidLaunchCostsCurrent	0	usd
CY2022Q4	mnts	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	2841000	usd
CY2021Q4	mnts	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	4869000	usd
CY2022Q4	mnts	Prepaid Insurance And Other Assets Current PrepaidInsuranceAndOtherAssetsCurrent	4332000	usd
CY2021Q4	mnts	Prepaid Insurance And Other Assets Current PrepaidInsuranceAndOtherAssetsCurrent	4562000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10173000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9431000	usd
CY2022Q4	mnts	Prepaid Launch Costs Noncurrent PrepaidLaunchCostsNoncurrent	4400000	usd
CY2021Q4	mnts	Prepaid Launch Costs Noncurrent PrepaidLaunchCostsNoncurrent	3000000	usd
CY2021Q2	mnts	Number Of Launch Service Agreements Terminated NumberOfLaunchServiceAgreementsTerminated	2	agreement
CY2022	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	usd
CY2022	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	usd
CY2021	mnts	Other Impairment Of Ongoing Project OtherImpairmentOfOngoingProject	800000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1200000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12000	usd
CY2022Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	600000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	600000	usd
CY2022	mnts	Prepaid Launch Costs Impairment PrepaidLaunchCostsImpairment	1800000	usd
CY2022Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5808000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6656000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1792000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1827000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4016000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4829000	usd
CY2022	us-gaap	Depreciation Depreciation	1000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	461000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	124000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	337000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	447000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	98000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	107000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	50000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	50000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	50000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	87000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	337000	usd
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11000000	usd
CY2021Q4	mnts	Lessee Operating Lease Number Of Leases Modified LesseeOperatingLeaseNumberOfLeasesModified	2	lease
CY2022Q4	mnts	Lessee Operating Lease Number Of Leases Modified LesseeOperatingLeaseNumberOfLeasesModified	1	lease
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1609000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1742000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	611000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	590000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	38000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	19000	usd
CY2022	us-gaap	Lease Cost LeaseCost	2258000	usd
CY2021	us-gaap	Lease Cost LeaseCost	2351000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1533000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1580000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1627000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1674000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1729000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	297000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8440000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1156000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7284000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3128000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4121000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3584000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3862000	usd
CY2022Q4	mnts	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	981000	usd
CY2021Q4	mnts	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	1240000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	333000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	399000	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	0	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	163000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8026000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9785000	usd
CY2021	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	30900000	usd
CY2021Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	78000000	usd
CY2021Q3	mnts	Stock Issued During Period Value Conversion Of Safe Notes StockIssuedDuringPeriodValueConversionOfSAFENotes	136000000	usd
CY2021	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	209300000	usd
CY2021Q3	mnts	Common And Preferred Stock Shares Authorized CommonAndPreferredStockSharesAuthorized	270000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79772262	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79772262	shares
CY2021Q3	mnts	Common Stock Percentage Of Ownership After Reverse Recapitalization CommonStockPercentageOfOwnershipAfterReverseRecapitalization	1
CY2021Q2	mnts	Reverse Recapitalization Percentage Of Voting Interests Acquired ReverseRecapitalizationPercentageOfVotingInterestsAcquired	1
CY2021Q2	mnts	Reverse Recapitalization Initial Consideration Transferred To Each Co Founder ReverseRecapitalizationInitialConsiderationTransferredToEachCoFounder	1	usd
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	50000000	usd
CY2021Q2	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	247300000	usd
CY2021Q2	mnts	Reverse Recapitalization Payments To Co Founders ReverseRecapitalizationPaymentsToCoFounders	40000000	usd
CY2021Q2	mnts	Business Combination Initial Consideration Transferred To Co Founders BusinessCombinationInitialConsiderationTransferredToCoFounders	3	usd
CY2021Q2	mnts	Reverse Recapitalization Release Of Proceeds From Shareholders Period Without Objection ReverseRecapitalizationReleaseOfProceedsFromShareholdersPeriodWithoutObjection	P15D
CY2021Q2	mnts	Proceeds From Sale Of Business And Other Capital Raising Transactions From Co Founders Minimum ProceedsFromSaleOfBusinessAndOtherCapitalRaisingTransactionsFromCoFoundersMinimum	2700000	usd
CY2022Q4	mnts	Business Combination Contingent Consideration Liability To Co Founders BusinessCombinationContingentConsiderationLiabilityToCoFounders	10000000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4040360	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.27
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1064862	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.54
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2184961	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.26
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	363528	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.28
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2556733	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	763000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1371124	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.71
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y1M6D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	571000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2556733	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.21
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	763000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5100000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	18000000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11580000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18452000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11580000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18452000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-95444000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	120654000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-95444000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	120654000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81546648	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65177873	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5438952	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	301952	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81546648	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70918777	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.17
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.85
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.17
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27750724	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	22927491	shares
CY2022Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	15368000	usd
CY2022Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	600000	usd
CY2022Q4	mnts	Unrecorded Unconditional Purchase Obligation To Be Paid After Year Two UnrecordedUnconditionalPurchaseObligationToBePaidAfterYearTwo	0	usd
CY2022Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	15968000	usd
CY2021Q2	mnts	Reverse Recapitalization Percentage Of Voting Interests Acquired ReverseRecapitalizationPercentageOfVotingInterestsAcquired	1
CY2021Q2	mnts	Reverse Recapitalization Initial Consideration Transferred To Each Co Founder ReverseRecapitalizationInitialConsiderationTransferredToEachCoFounder	1	usd
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	50000000	usd
CY2021Q2	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	247300000	usd
CY2021Q2	mnts	Reverse Recapitalization Payments To Co Founders ReverseRecapitalizationPaymentsToCoFounders	40000000	usd
CY2021Q2	mnts	Business Combination Initial Consideration Transferred To Co Founders BusinessCombinationInitialConsiderationTransferredToCoFounders	3	usd
CY2021Q2	mnts	Reverse Recapitalization Release Of Proceeds From Shareholders Period Without Objection ReverseRecapitalizationReleaseOfProceedsFromShareholdersPeriodWithoutObjection	P15D
CY2021Q2	mnts	Proceeds From Sale Of Business And Other Capital Raising Transactions From Co Founders Minimum ProceedsFromSaleOfBusinessAndOtherCapitalRaisingTransactionsFromCoFoundersMinimum	2700000	usd
CY2022Q4	mnts	Business Combination Contingent Consideration Liability To Co Founders BusinessCombinationContingentConsiderationLiabilityToCoFounders	10000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-95444000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	120656000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-95444000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	120656000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-20042000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	25338000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	11113000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.116
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-8446000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.070
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-60000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.001
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3426000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.028
CY2022	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	1089000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-0.011
CY2021	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	51790000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.429
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-143000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	171000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1085000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.011
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1333000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.011
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	276000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.003
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	336000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.003
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11030000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.116
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	32300000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.268
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	17922000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	16473000	usd
CY2022Q4	mnts	Deferred Tax Assets Start Up And Organizational Costs DeferredTaxAssetsStartUpAndOrganizationalCosts	16965000	usd
CY2021Q4	mnts	Deferred Tax Assets Start Up And Organizational Costs DeferredTaxAssetsStartUpAndOrganizationalCosts	15311000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16562000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10350000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4595000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3758000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3072000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1457000	usd
CY2022Q4	mnts	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	1534000	usd
CY2021Q4	mnts	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	2381000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1710000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1070000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	173000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	586000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	22000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	26000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	893000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	62556000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	52305000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	61200000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	50168000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1356000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2137000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1356000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2137000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1356000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2137000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	61200000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1253000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	163000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	442000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1532000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	84300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	80600000	usd
CY2022Q4	mnts	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	1500000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1400000	usd

Files In Submission

Name	View Source	Status
0001781162-23-000015-index-headers.html	Edgar Link	pending
0001781162-23-000015-index.html	Edgar Link	pending
0001781162-23-000015.txt	Edgar Link	pending
0001781162-23-000015-xbrl.zip	Edgar Link	pending
a20221231-ex311xceo.htm	Edgar Link	pending
a20221231-ex312xcfo.htm	Edgar Link	pending
a20221231-ex321xceo.htm	Edgar Link	pending
a20221231-ex322xcfo.htm	Edgar Link	pending
consenttemplatev362023.htm	Edgar Link	pending
consenttemplatev362023001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mnts-20221231.htm	Edgar Link	pending
mnts-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mnts-20221231_cal.xml	Edgar Link	unprocessable
mnts-20221231_def.xml	Edgar Link	unprocessable
mnts-20221231_lab.xml	Edgar Link	unprocessable
mnts-20221231_pre.xml	Edgar Link	unprocessable
mnts-20221231_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNTS
Momentus Inc. Stock $mnts

2023 Q1 Form 10-K Financial Statement

#000178116223000015 Filed on March 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTS Momentus Inc. Stock $mnts

2023 Q1 Form 10-K Financial Statement

#000178116223000015 Filed on March 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTS
Momentus Inc. Stock $mnts